2 not yet recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow LinGang Laboratory: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder Major Depressive Disorder (MDD) | Not yet recruiting | Shanghai Mental Health Center | 150 | 2027-09-01 | 2026-08-03 | |
| An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants Cohort 1: LG-0317 20 mg, Cohort 1: LG-0317 40 mg, Cohort 1: LG-0317 80 mg - Healthy Volunteers (HV) | Phase 1 | Not yet recruiting | LinGang Laboratory | 12 | 2026-07-24 | 2026-07-16 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants LG-0317, Placebo - Healthy Volunteers | Phase 1 | Recruiting | LinGang Laboratory | 100 | 2026-04-20 | 2026-06-25 |
Depressive Disorder, Major (1)
China (2)
Shen He (1)